Sufentanil Citrate (Hospira, Inc.)
Welcome to the PulseAid listing for the Sufentanil Citrate drug offered from Hospira, Inc.. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | SUFENTANIL CITRATE |
SUBSTANCE NAME: | SUFENTANIL CITRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
ROUTE: | EPIDURAL; INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2005-09-07 |
END MARKETING DATE: | 0000-00-00 |
Sufentanil Citrate HUMAN PRESCRIPTION DRUG Details:
Item Description | Sufentanil Citrate from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 50(ug/mL) |
START MARKETING DATE: | 2005-09-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-3380_1aab2d47-62d1-4fc7-ba5e-f92a5e6262a9 |
PRODUCT NDC: | 0409-3380 |
APPLICATION NUMBER: | ANDA074534 |
Other SUFENTANIL CITRATE Pharmaceutical Manufacturers / Labelers: